Kidist Yimam

1.1k total citations
21 papers, 312 citations indexed

About

Kidist Yimam is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kidist Yimam has authored 21 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kidist Yimam's work include Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Gallbladder and Bile Duct Disorders (5 papers). Kidist Yimam is often cited by papers focused on Liver Diseases and Immunity (10 papers), Liver Disease Diagnosis and Treatment (6 papers) and Gallbladder and Bile Duct Disorders (5 papers). Kidist Yimam collaborates with scholars based in United States, Canada and United Kingdom. Kidist Yimam's co-authors include Christopher L. Bowlus, Edward W. Holt, Homie Razavi, Chris Estes, Palak Trivedi, R. Todd Frederick, Cynthia Levy, Raphael B. Merriman, Paul J. Pockros and Bertus Eksteen and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Kidist Yimam

19 papers receiving 308 citations

Peers

Kidist Yimam

HEPAT

EPIDE

SURGE

PRM

ONCOL

David Parlier France

Matthew L. Holzner United States

K. Thrum Germany

Richard Knoop Germany

Jun Kadono Japan

Melvin Lau United States

O. Farges France

Marian M. Claessen Netherlands

Jean‐Christian Audigier France

Michèle D. Bishop United States

David Parlier France

Kidist Yimam

185 ×0.9

HEPAT

178 ×1.3

EPIDE

77 ×0.6

SURGE

90 ×0.8

PRM

112 ×1.9

ONCOL

Citations per year, relative to Kidist Yimam Kidist Yimam (= 1×) peers David Parlier

Countries citing papers authored by Kidist Yimam

Since Specialization

Citations

This map shows the geographic impact of Kidist Yimam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kidist Yimam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kidist Yimam more than expected).

Fields of papers citing papers by Kidist Yimam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kidist Yimam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kidist Yimam. The network helps show where Kidist Yimam may publish in the future.

Co-authorship network of co-authors of Kidist Yimam

This figure shows the co-authorship network connecting the top 25 collaborators of Kidist Yimam. A scholar is included among the top collaborators of Kidist Yimam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kidist Yimam. Kidist Yimam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yimam, Kidist, Alan Bonder, Kessendri Reddy, et al.. (2025). Alkaline Phosphatase Changes With Seladelpar Across Subgroups Of Primary Biliary Cholangitis Patients In The Response Trial. Digestive and Liver Disease. 57. S88–S88.

Yimam, Kidist, et al.. (2024). Cholestatic Pruritus: Pathophysiology, Current Management Approach, and Emerging Therapies. Current Hepatology Reports. 23(1). 123–136. 2 indexed citations

Trauner, Michael, Cynthia Levy, Atsushi Tanaka, et al.. (2023). A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of cilofexor in patients with non-cirrhotic primary sclerosing cholangitis (PRIMIS). Journal of Hepatology. 78. S12–S13. 8 indexed citations

Trivedi, Palak, Christopher L. Bowlus, Kidist Yimam, Homie Razavi, & Chris Estes. (2021). Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies. Clinical Gastroenterology and Hepatology. 20(8). 1687–1700.e4. 60 indexed citations

Eksteen, Bertus, Christopher L. Bowlus, Aldo J. Montaño‐Loza, et al.. (2020). Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study. Hepatology Communications. 5(3). 478–490. 35 indexed citations

Holt, Edward W., et al.. (2020). Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches. Journal of Clinical and Translational Hepatology. X(X). 1–12. 34 indexed citations

Majid, Shahana, David de Semir, Vladimir Bezrookove, et al.. (2019). Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma. Oncogenesis. 8(8). 42–42. 40 indexed citations

Frenette, Catherine, Aparna Goel, Sonal Kumar, et al.. (2019). Practical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel. BMJ Open Gastroenterology. 6(1). e000256–e000256. 20 indexed citations

Goldberg, David S., Cynthia Levy, Kidist Yimam, et al.. (2017). Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium. Clinical Gastroenterology and Hepatology. 16(4). 591–593. 21 indexed citations

10.

Singh, Virendra, Edward W. Holt, Adil E. Wakil, et al.. (2015). P0897 : Efficacy of simeprevir and sofosbuvir for treatment of cirrhotic patients with genotype 1 chronic hepatitis C – a single center experience. Journal of Hepatology. 62. S680–S680. 1 indexed citations

11.

Holt, Edward W., et al.. (2014). Patient Tolerability of Bowel Preparation is Associated with Polyp Detection Rate During Colonoscopy. Journal of Gastrointestinal and Liver Diseases. 23(2). 135–140. 18 indexed citations

12.

Yimam, Kidist & Christopher L. Bowlus. (2014). Diagnosis and classification of primary sclerosing cholangitis. Autoimmunity Reviews. 13(4-5). 445–450. 37 indexed citations

13.

Yimam, Kidist & Christopher L. Bowlus. (2014). Obeticholic acid for the treatment of primary biliary cirrhosis. Expert Opinion on Orphan Drugs. 2(12). 1351–1358. 4 indexed citations

14.

Holt, Edward W., et al.. (2013). Esophageal adenocarcinoma in a 40-year-old man with cystic fibrosis: coincidence or not?. PubMed. 13(2). 252–5. 7 indexed citations

15.

Yimam, Kidist, Raphael B. Merriman, & R. Todd Frederick. (2013). A rare case of acute hepatitis B virus infection causing guillain-barré syndrome.. PubMed. 9(2). 121–3. 14 indexed citations

16.

Holt, Edward W., et al.. (2012). Su1441 Later Queue Position in the Endoscopy Schedule Is Independently Associated With Lower Detection of Right-Sided Polyps and Adenomas. Gastrointestinal Endoscopy. 75(4). AB332–AB333. 1 indexed citations

17.

Yimam, Kidist, et al.. (2012). Older Age Is Associated with a Higher Incidence Colonic Adenomas During Colonoscopy. The American Journal of Gastroenterology. 107. S223–S223.

18.

Yimam, Kidist, et al.. (2012). 910 A Prospective Study Evaluating the Association Between Timing and Quality of Bowel Preparation for Colonoscopy and Adenoma Detection Rate. Gastrointestinal Endoscopy. 75(4). AB170–AB170. 2 indexed citations

19.

Yimam, Kidist, et al.. (2011). Acute Hepatitis B Infection Causing Guillain-Barré Syndrome (GBS): A Rare Case: 2011 ACG Presidential Poster. The American Journal of Gastroenterology. 106. S299–S300. 1 indexed citations

20.

Holt, Edward W., et al.. (2011). Esophageal Adenocarcinoma in a 40 Year-Old Man with Cystic Fibrosis: Coincidence or Not?. The American Journal of Gastroenterology. 106. S175–S176. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact